To evaluate the biological functions of KRAS and NAP1L1 in RCC, we performed GSEA to link the published gene array analysis to different-stage RCC patient tissues versus matched normal kidney tissue signatures (GEO Datasets: GSE6344; GO_0006954 and GO_0007155). Here, KRAS is linked to renal cell carcinoma.